Meningococcal B vax shown to protect against gonorrhoea

THE MeNZB vaccine of the mid 2000s offers protection against gonorrhoea, University of Auckland researchers have found.

A case-controlled study reviewed 15,000 patient files in sexual health clinics across the country, and found 30% of individuals vaccinated against meningococcal B with MeNZB were protected against gonorrhoea.

Helen Petousis-Harris, director of immunisation research and vaccinology at the University of Auckland Immunisation Advisory Centre, led the research team and presented her findings at the International Pathogenic Neisseria Conference in Manchester, England